NetworkNewsWire Editorial Coverage NEW YORK, July 9, 2025 /PRNewswire/ -- Each year, approximately 20 million people are diagnosed with cancer, and nearly ...

Hundreds of people with cystic fibrosis are to be offered a once-a-day pill which has been hailed as “life changing” by health experts.

An estimated 20 million people are diagnosed annually with cancer, while cancer kills almost 10 million people a year worldwide ( with these numbers expected to grow. The American Cancer Society ...

Vertex Pharmaceuticals (VRTX) announced that Health Canada has granted Marketing Authorization for ALYFTREK, a new triple combination therapy for ...

NHS England agreed to reimburse Vertex's newest cystic fibrosis medicine. Meanwhile, Merck advanced a once-monthly PrEP pill ...

A favorite among tuners and commuters, the Honda K-Series engines have powered everything from everyday driving to track days, and everything in between.

HOUSTON, July 9, 2025 /PRNewswire/ -- Summit Midstream Corporation (NYSE: SMC) ("Summit", "SMC" or the "Corporation") announced today that its 2024 Schedule K-3 packages for Summit Midstream ...

Summit Midstream Corporation (NYSE: SMC) ("Summit", "SMC" or the "Corporation") announced today that its 2024 Schedule K-3 packages for Summit Midstream Partners, LP are now available online ...

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 were able to come off insulin within a year.

The results of the review will need to be reflected in its financial statements for fiscal 2025 in the Company's Annual Report on Form 10-K.

Denver, Colorado--(Newsfile Corp. - July 11, 2025) - 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that Siyata ...

Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial stage medical device and biopharmaceutical ...